SEC Form 4 · accession 0001140361-15-007867

IDEXX LABORATORIES INC /DE · IDXX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Michael J Williams Ph.D.

Officer — Executive Vice President

Period of report

Feb 14, 2015

Accepted (ET)

Feb 18, 2015 · 6:37 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000874716

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Feb 14, 2015	M	202	$0.00	A	14,279	D
Common Stock	Feb 14, 2015	M	273	$0.00	A	14,552	D
Common Stock	Feb 14, 2015	M	257	$0.00	A	14,809	D
Common Stock	Feb 14, 2015	M	258	$0.00	A	15,067	D
Common Stock	Feb 14, 2015	M	398	$0.00	A	15,465	D
Common Stock	Feb 14, 2015	F	121	$159.08	D	15,344	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F2	$159.08	Feb 14, 2015	A	13,424	A	—	Feb 13, 2025	Common Stock	13,424	13,424	D
Incentive Stock Option (right to buy)^F3	$159.08	Feb 14, 2015	A	628	A	—	Feb 13, 2025	Common Stock	628	628	D
Restricted Stock Unit^F4	—	Feb 14, 2015	A	1,179	A	—	—	Common Stock	1,179	9,482	D
Restricted Stock Unit^F5	—	Feb 14, 2015	M	202	D	—	—	Common Stock	202	9,280	D
Restricted Stock Unit^F6	—	Feb 14, 2015	M	273	D	—	—	Common Stock	273	9,007	D
Restricted Stock Unit^F7	—	Feb 14, 2015	M	257	D	—	—	Common Stock	257	8,750	D
Restricted Stock Unit^F8	—	Feb 14, 2015	M	258	D	—	—	Common Stock	258	8,492	D
Restricted Stock Unit^F9	—	Feb 14, 2015	M	398	D	—	—	Common Stock	398	8,094	D

Explanation of responses

F1Includes 44 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2014.
F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that becomes exercisable as to 2,811 shares on 02/14/2016 and 02/14/2017, 2,810 shares on 02/14/2018 and 02/14/2019, and the remaining 2,182 shares on 02/14/2020.
F3Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests on the fifth anniversary date (02/14/2020) of the grant.
F4Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.
F5Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.
F6Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.
F7Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
F8Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
F9Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.